Chemical Formula: C36H60O8

Chemical Formula C36H60O8

Found 57 metabolite its formula value is C36H60O8

Ginsenoside Rh4

2-({5,16-dihydroxy-2,6,6,10,11-pentamethyl-14-[(2E)-6-methylhepta-2,5-dien-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-8-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.428796)

Ginsenoside Rh4 is found in tea. Ginsenoside Rh4 is isolated from ginseng. Isolated from ginseng. Ginsenoside Rh4 is found in tea.

Soyasapogenol B 24-O-b-D-glucoside

2-[(3,9-dihydroxy-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-4-yl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.428796)

Soyasapogenol B 24-O-b-D-glucoside is found in pulses. Soyasapogenol B 24-O-b-D-glucoside is a constituent of French bean seeds (Phaseolus vulgaris). Constituent of French bean seeds (Phaseolus vulgaris). Soyasapogenol B 24-O-b-D-glucoside is found in pulses, yellow wax bean, and green bean.

(3b,7b,22x)-Cucurbita-5,24-diene-3,7,23-triol 7-glucoside

2-{[5-hydroxy-14-(4-hydroxy-6-methylhept-5-en-2-yl)-1,6,6,11,15-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.428796)

(3b,7b,22x)-Cucurbita-5,24-diene-3,7,23-triol 7-glucoside is found in fruits. (3b,7b,22x)-Cucurbita-5,24-diene-3,7,23-triol 7-glucoside is a constituent of Momordica charantia (bitter melon). Constituent of Momordica charantia (bitter melon). (3b,7b,22x)-Cucurbita-5,24-diene-3,7,23-triol 7-glucoside is found in fruits.

Fasciculic acid A

5-{[14-(5,6-dihydroxy-6-methylheptan-2-yl)-5-hydroxy-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-4-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C36H60O8 (620.428796)

Fasciculic acid A is found in mushrooms. Fasciculic acid A is from the toxic sulphur tuft mushroom Naematoloma fasciculare. From the toxic sulphur tuft mushroom Naematoloma fasciculare. Fasciculic acid A is found in mushrooms.

DG(13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5R,6R,7Z,9Z,11E,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C36H60O8 (620.428796)

DG(13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C36H60O8 (620.428796)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C36H60O8 (620.428796)

DG(13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C36H60O8 (620.428796)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5R,6R,7Z,11E,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C36H60O8 (620.428796)

DG(a-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5S,6S,7Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C36H60O8 (620.428796)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C36H60O8 (620.428796)

DG(a-13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C36H60O8 (620.428796)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5R,6R,7Z,11E,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C36H60O8 (620.428796)

DG(i-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5S,6S,7Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C36H60O8 (620.428796)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C36H60O8 (620.428796)

DG(i-13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C36H60O8 (620.428796)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

3-O-(beta-D-Glucopyranosyl)-soyasapogenol B

(2R,3R,4S,5S,6R)-2-{[(3S,4R,6aR,6bS,8aR,9R,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.428796)

3-o-(beta-d-glucopyranosyl)-soyasapogenol b is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 3-o-(beta-d-glucopyranosyl)-soyasapogenol b can be found in soy bean, which makes 3-o-(beta-d-glucopyranosyl)-soyasapogenol b a potential biomarker for the consumption of this food product.

Ginsenoside Rk3

(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.428796)

Ginsenoside Rk3 is a natural product found in Panax ginseng and Panax notoginseng with data available. Ginsenoside Rk3 is present in the roots Panax ginseng herbs. Ginsenoside Rk3 significantly inhibits TNF-α-induced NF-κB transcriptional activity, with an IC50 of 14.24±1.30 μM in HepG2 cells. Ginsenoside Rk3 is present in the roots Panax ginseng herbs. Ginsenoside Rk3 significantly inhibits TNF-α-induced NF-κB transcriptional activity, with an IC50 of 14.24±1.30 μM in HepG2 cells.

Ginsenoside RH4

(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2E)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.428796)

Ginsenoside Rh4 is a triterpenoid saponin. Ginsenoside Rh4 is a natural product found in Panax vietnamensis and Panax notoginseng with data available.

24-methylenecycloartane-3beta,6beta,7beta16beta-tetraol 3-Obeta-D-xylopyranoside

C36H60O8 (620.428796)

bafilomycin J

C36H60O8 (620.428796)

3beta,20(S)-dihydroxydammar-24-en-12beta,23beta-epoxy-20-O-beta-D-glucopyranoside

C36H60O8 (620.428796)

3-beta,23,28-trihydroxy-olean-12-en-3-O-beta-D-glucopyranoside

C36H60O8 (620.428796)

soyasapogenol B-22-O-beta-D-glucoside

C36H60O8 (620.428796)

Fasciculic acid A

5-{[14-(5,6-dihydroxy-6-methylheptan-2-yl)-5-hydroxy-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-4-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C36H60O8 (620.428796)

(3b,7b,22x)-Cucurbita-5,24-diene-3,7,23-triol 7-glucoside

2-{[5-hydroxy-14-(4-hydroxy-6-methylhept-5-en-2-yl)-1,6,6,11,15-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.428796)

3-DPHMC

2-[(3,9-dihydroxy-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-4-yl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.428796)

6-O-beta-D-glucopyranosyldammar-20(22),24-diene-3beta,6alpha,12beta-triol

C36H60O8 (620.428796)

Sigmoside C

C36H60O8 (620.428796)

3-Glc-soyasapogenol B

C36H60O8 (620.428796)

23-Glc-soyasapogenol B

C36H60O8 (620.428796)

DG(13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C36H60O8 (620.428796)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/13:0/0:0)

C36H60O8 (620.428796)

DG(13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C36H60O8 (620.428796)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/13:0)

C36H60O8 (620.428796)

DG(a-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C36H60O8 (620.428796)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/a-13:0/0:0)

C36H60O8 (620.428796)

DG(a-13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C36H60O8 (620.428796)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/a-13:0)

C36H60O8 (620.428796)

DG(i-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C36H60O8 (620.428796)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-13:0/0:0)

C36H60O8 (620.428796)

DG(i-13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C36H60O8 (620.428796)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/i-13:0)

C36H60O8 (620.428796)

12-Deoxyfasciculic acid B

C36H60O8 (620.428796)

Soyasapogenol B 24-O-b-D-glucoside

C36H60O8 (620.428796)

7-hydroxy-2,2,5a,7-tetramethyl-6-(2-{1,4,4,6-tetramethyl-1-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-hexahydro-2h-azulen-5-ylidene}ethyl)-hexahydro-1-benzoxepin-3-one

C36H60O8 (620.428796)

3-[(3s,3as,4r,5ar,6s,7s,9ar,9br)-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

3-[(3s,3as,4r,5ar,6s,7s,9ar,9br)-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C36H60O8 (620.428796)

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-1-(6-methylhepta-1,5-dien-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-1-(6-methylhepta-1,5-dien-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.428796)